Skip to content
Research Article Open access CC BY 4.0

Diagnostic Utility of Plasma Chitotriosidase, Total Acid Phosphatase Activity, Ferritin and Globulin Levels in Screening for Gaucher Disease

Mohammed H. Hassan, Ayat A. Sayed, Ahmed El-Abd Ahmed, Tahia H. Saleem

International Journal of Biochemistry Research & Review · pp. 1–8 · Published 5 May 2017

10.9734/IJBCRR/2017/32782

Abstract

Aims: Gaucher disease "GD" is one of the most common glycolipid storage disorders. Several circulating molecules thought to be secreted by Gaucher cells have been studied as biological markers of disease. We investigate and compare the validity of using plasma chitotriosidase "ChT", total acid phosphatase activity, ferritin, and globulin in predicting GD in pediatric patients. Methodology: A cross sectional hospital based study, carried out on 43 pediatric patients (23 GD patients and 20 patients with suspected storage disorder). Complete blood counts, globulin assays, calculated A/G ratio, β-glucocerebrosidase activity assays, plasma protein electrophoresis, ELISA assays of plasma ChT and ferritin, colorimetric assay of plasma total acid phosphatase activity and GBA gene mutation analysis, were done for the included patients. Results: Significantly higher plasma ChT levels and increased total acid phosphatase activity were observed in GD patients versus those suspected to have storage disorders (P-value <0.05). High plasma ChT and ferritin have higher sensitivity, while high plasma total acid phosphatase activity, and globulin and low A/G ratio have higher specificity in diagnosing GD. Conclusions: Plasma ChT and total acid phosphatase activity, both together are more valid than ferritin and globulin in screening for GD.

Chitotriosidase total acid phosphatase activity ferritin globulin Gaucher disease screening

References (17)

  1. 1 Gaucher Cells Demonstrate a Distinct Macrophage Phenotype and Resemble Alternatively Activated Macrophages [DOI]
  2. 2 Chitinases: in agriculture and human healthcare [DOI]
  3. 3 Gaucher disease: haematological presentations and complications [DOI]
  4. 4 Immunoglobulin and free light chain abnormalities in Gaucher disease type I: data from an adult cohort of 63 patients and review of the literature [DOI]
  5. 5 Value of plasma chitotriosidase to assess non‐neuronopathic Gaucher disease severity and progression in the era of enzyme replacement therapy [DOI]
  6. 6 Plasma chitotriosidase activity in children with lysosomal storage disorders [DOI]
  7. 7 Identification and use of biomarkers in Gaucher disease and other lysosomal storage diseases [DOI]
  8. 8 Correlation of surrogate markers of Gaucher disease. Implications for long-term follow up of enzyme replacement therapy [DOI]
  9. 9 Chitotriosidase variants in patients with Gaucher disease. Implications for diagnosis and therapeutic monitoring [DOI]
  10. 10 The prognostic value of the serum ferritin in a southern Brazilian cohort of patients with Gaucher disease [DOI]
  11. 11 Clinical and genetic assessment of pediatric patients with Gaucher’s disease in Upper Egypt [DOI]
  12. 12 Acid phosphatase in Gaucher's disease. [DOI]
  13. 13 Immunoglobulin abnormalities and effects of enzyme replacement therapy in children with Gaucher disease [DOI]
  14. 14 Gaucher disease in Arab patients at an Israeli referral clinic.
  15. 15 Acid Phosphatase in Gaucher's Disease [DOI]
  16. 16 Effect of Enzyme Replacement Therapy on Disease Burden Biomarkers in Gaucher's Disease [DOI]
  17. 17 The Israel Medical Association journal [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

133

Page views

0

PDF downloads

34

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.